NanoString Technologies Garners $15,300,000 Series E Financing Round

  • Feed Type
  • Date
    12/3/2012
  • Company Name
    NanoString Technologies
  • Mailing Address
    530 Fairview Ave N Seattle, WA 98109
  • Company Description
    NanoString Technologies is developing a patent pending platform for single molecule identification and digital quantification. The NanoString system uniquely barcodes individual target molecules, scans them, and delivers a literal inventory of target molecules in the biological sample.
  • Website
    http://www.nanostring.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,300,000
  • Transaction Round
    Series E
  • Proceeds Purposes
    The proceeds of the financing will be used to support the expansion of NanoString’s existing life sciences business and its first commercial launch in molecular diagnostics.
  • M&A Terms
  • Venture Investor
    Morgan Stanley Expansion Capital
  • Venture Investor
    AllianceBernstein
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    Draper Fisher Jurvetson
  • Venture Investor
    OVP Venture Partners
  • Venture Investor
    GE Healthymagination Fund
  • Venture Investor
    BioMed Ventures
  • Venture Investor
    Individual Investor

By posting a comment, you agree to our terms and conditions.